Congo, Democratic Republic of the vs Nigeria: Immunization, Hib3
Immunization, Hib3 over time
- Congo, Democratic Republic of the
- Nigeria
How they compare
Nigeria currently reports 67.0% against 65.0% in Congo, Democratic Republic of the, a difference of 2.0%.
The two have swapped places 1 time across 13 shared years of data; in 2012 it was Congo, Democratic Republic of the ahead.
Congo, Democratic Republic of the ranks 176th and Nigeria ranks 174th of 191 countries.
Congo, Democratic Republic of the has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Congo, Democratic Republic of the | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 71.2% | 44.6% | 26.6% | Congo, Democratic Republic of the |
| 2020s | 65.0% | 63.2% | 1.8% | Congo, Democratic Republic of the |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Congo, Democratic Republic of the or Nigeria?
- Nigeria, at 67.0% against 65.0% in Congo, Democratic Republic of the as of 2024.
- What is the difference in immunization, hib3 between Congo, Democratic Republic of the and Nigeria?
- 2.0%, with Nigeria ahead.
- How many years of comparable data are there for Congo, Democratic Republic of the and Nigeria?
- 13 years are reported by both, from 2012 to 2024.
- How do Congo, Democratic Republic of the and Nigeria rank globally for immunization, hib3?
- Congo, Democratic Republic of the ranks 176th and Nigeria ranks 174th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.